Indegene Ltd (NSE:INDGN) — Market Cap & Net Worth
Market Cap & Net Worth: Indegene Ltd (INDGN)
Indegene Ltd (NSE:INDGN) has a market capitalization of $1.34 Billion (Rs123.98 Billion) as of June 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #7839 globally and #376 in its home market, demonstrating a -1.43% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Indegene Ltd's stock price Rs515.90 by its total outstanding shares 240317117 (240.32 Million). Review Indegene Ltd total liabilities to assess the company's total debt and financial obligations.
Indegene Ltd Market Cap History: 2024 to 2026
Indegene Ltd's market capitalization history from 2024 to 2026. Data shows change from $1.57 Billion to $1.34 Billion (-4.72% CAGR).
Index Memberships
Indegene Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$3.13 Trillion | 0.04% | #311 of 500 |
|
NIFTY SMALLCAP 250
NISM250
|
$388.18 Billion | 0.35% | #125 of 250 |
Weight: Indegene Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Indegene Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Indegene Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Indegene Ltd's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.33x
Indegene Ltd's market cap is 0.33 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $1.57 Billion | $25.90 Billion | $3.37 Billion | 0.06x | 0.47x |
| 2025 | $1.35 Billion | $28.39 Billion | $4.07 Billion | 0.05x | 0.33x |
| 2026 | $1.34 Billion | $35.10 Billion | $4.01 Billion | 0.04x | 0.33x |
Competitor Companies of INDGN by Market Capitalization
Companies near Indegene Ltd in the global market cap rankings as of June 19, 2026.
Key companies related to Indegene Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #1066 globally with a market cap of $25.15 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1911 globally with a market cap of $12.48 Billion USD ( AU$17.64 Billion AUD).
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2171 globally with a market cap of $10.63 Billion USD.
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2547 globally with a market cap of $8.48 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1066 | Veeva Systems Inc Class A | NYSE:VEEV | $25.15 Billion | $154.85 |
| #1911 | Pro Medicus Ltd | AU:PME | $12.48 Billion | AU$168.90 |
| #2171 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $64.43 |
| #2547 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $8.48 Billion | $48.79 |
Indegene Ltd Historical Marketcap From 2024 to 2026
Between 2024 and today, Indegene Ltd's market cap moved from $1.57 Billion to $ 1.34 Billion, with a yearly change of -4.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs1.34 Billion | -0.87% |
| 2025 | Rs1.35 Billion | -13.79% |
| 2024 | Rs1.57 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Indegene Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.34 Billion USD |
| MoneyControl | $1.34 Billion USD |
| MarketWatch | $1.34 Billion USD |
| marketcap.company | $1.34 Billion USD |
| Reuters | $1.34 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Indegene Ltd
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It al… Read more